Abstract
Background
99mTc-labeled teboroxime undergoes rapid washout from the myocardium. For this reason, its use has been favored in conjunction with pharmacologic stress, which enables patient positioning before tracer administration, and multidetector single-photon emission computed tomography (SPECT), which enables rapid acquisition. We evaluated treadmill exercise 99mTc-labeled teboroxime SPECT with single-detector systems for the detection of coronary artery disease.
Methods and Results
Treadmill exercise 99mTc-labeled teboroxime SPECT was compared with analogous 201TI-labeled imaging in 108 patients. Teboroxime was injected first during exercise and then at rest. Nine myocardial segments per study were scored with respect to uptake of activity during stress and at rest (teboroxime) or after redistribution (201TI). Perfusion was defined as normal, reversible, or fixed. Overall agreement of 201TI versus teboroxime segmental perfusion (normal vs abnormal) was 772/961 (80.3%; \gc2 = 258; p<0.001; κ=0.51) or (normal vs reversible vs fixed) 711/961 (74.0%; \gc2 = 296; p<0.001; κ=0.42). Fifty-six patients also underwent selective coronary angiography. Stenoses greater than 50% of lumenal diameter were drawn on individualized coronary artery diagrams applied to polar plots of scintigraphic segments to compare detection of coronary artery disease. Sensitivity and accuracy of teboroxime were 0.80 and 0.79, respectively, compared with 0.84 and 0.82 for 201TI (difference not significant). Mean imaging procedure time was 113.6 minutes for teboroxime and 240.5 minutes for 201TI (p<0.001).
Conclusions
99mTc-labeled teboroxime is amenable to simple modifications of routine treadmill exercise SPECT myocardial perfusion imaging protocols with widely available single-detector SPECT systems. This modality provides results similar to those of exercise 201TI SPECT and is significantly faster.
Similar content being viewed by others
References
Iskandrian AS, Heo J, Nguyen T, Mercuro J. Myocardial imaging with teboroxime: technique and initial results. Am Heart J 1991;121:889–94.
Leppo JA, DePuey G, Johnson LL. A review of cardiac imaging with sestamibi and teboroxime. J Nucl Med 1991;32:2012–22.
Burns RJ, Wright L. Three-minute acquisition of exercise Tc-99m teboroxime cardiac SPECT with a single-head detector [Abstract]. J Nucl Med 1991;32:929–30.
Chua T, Kiat H, Germano G, et al. Rapid back to back adenosine stress/rest technetium-99m teboroxime myocardial perfusion SPECT using a triple-detector camera. J Nucl Med 1993; 34:1485–93.
Links JM, Frank TL, Becker LC. Effect of differential tracer washout during SPECT acquisition. J Nucl Med 1991;32:2253–7.
Johnson LL, Rodney RA, Vaccarino RA, et al. Left ventricular perfusion and performance from a single radiopharmaceutical and one camera. J Nucl Med 1992;33:1411–6.
Stewart RE, Heyl B, O’Rourke RA, Bleimhardt R, Miller DD. Demonstration of differential poststenotic myocardial technetium-99m-teboroxime clearance kinetics after experimental ischemia and hyperemic stress. J Nucl Med 1991;32:2000–8.
Johnson LL, Seldin DW. Clinical experience with technetium-99m teboroxime, a neutral, lipophilic myocardial perfusion imaging agent. Am J Cardiol 1990;66:63E-7E.
Serafini AN, Topchik S, Jiminez H, Friden A, Ganz WI, Sfakianakis GN. Clinical comparison of technetium-99m-teboroxime and thallium-201 utilizing a continuous SPECT imaging protocol. J Nucl Med 1992;33:1304–11.
Bontemps L, Geronicola-Trapali X, Sayegh Y, Delmas O, Etitti R, Andre-Fouet X. Technetium-99m teboroxime scintigraphy: clinical experience in patients referred for myocardial perfusion evaluation. Eur J Nucl Med 1991;18:732–9.
Iskandrian AS, Heo J, Nguyen T, et al. Tomographic myocardial perfusion imaging with technetium-99m teboroxime during adenosine-induced coronary hyperemia: correlation with thallium-201 imaging. J Am Coll Cardiol 1992;19:307–12.
Nakajima K, Taki J, Bunko H, et al. Dynamic acquisition with a three-headed SPECT system: application to technetium 99m-SQ30217 myocardial imaging. J Nucl Med 1991;32:1273–7.
Heo J, Iskandrian B, Cave V, Iskandrian AS. Single photon emission computed tomographic teboroxime imaging with a preprocessing mask technique. Am Heart J 1992;124:1603–8.
Seldin DW, Johnson LL, Blood DK, et al. Myocardial perfusion imaging with technetium-99m SQ30217: comparison with thallium-201 and coronary anatomy. J Nucl Med 1989; 30:312–9.
Fleming RM, Kirkeeide RL, Taegtmeyer H, Adyanthaya A, Cassidy DB, Goldstein RA. Comparison of technetium-99m teboroxime tomography with automated quantitative coronary arteriography and thallium-201 tomographic imaging. J Am Coll Cardiol 1991;17:1297–302.
Dahlberg ST, Weinstein H, Hendel RC, McSherry B, Leppo JA. Planar myocardial perfusion imaging with technetium-99m-teboroxime: comparison by vascular territory with thallium-201 and coronary angiography. J Nucl Med 1992;30:1783–8.
Wackers FJT, Bodenheimer M, Fleiss JL, Brown M, Multicenter Study on Silent Myocardial Ischemia (MSSMI) Thallium-201 Investigators. Factors affecting uniformity in interpretation of planar thallium-201 imaging in a multicenter trial. J Am Coll Cardiol 1993;21:1064–74.
Maddahi J, Kiat H, Van Train KF, et al. Myocardial perfusion imaging with technetium-99m sestamibi SPECT in the evaluation of coronary artery disease. Am J Cardiol 1990;66:55E-62E.
Bok BD, Bice AN, Clausen M, Wong DF, Wagner HN. Artifacts in camera based single photon emission tomography due to time activity variation. Eur J Nucl Med 1989;15:113–7.
Gray WA, Gewirtz H. Comparison of 99mTc-teboroxime with thallium for myocardial imaging in the presence of coronary artery stenosis. Circulation 1991;84:1796–807.
Maublant JC, Moins N, Gachon P, Renoux M, Zhong Z, Veyre A. Uptake of technetium-99m-teboroxime in cultured myocardial cells: comparison with thallium-201 and technetium-99m-sestamibi. J Nucl Med 1993;34:255–9.
Hendel RC, Dahlberg ST, Weinstein H, Leppo J. Comparison of teboroxime and thallium for the reversibility of exercise-induced myocardial perfusion defects. Am Heart J 1993;126:856–62.
Friedman J, Van Train K, Maddahi J, et al. “Upward creep” of the heart: a frequent source of false-positive reversible defects during thallium-201 stress-redistribution SPECT. J Nucl Med 1989;30:1718–22.
Bruce RA, Fisher LD, Hossack KF. Validation of exercise-enhanced risk assessment of coronary heart disease events: longitudinal changes in incidence in Seattle community practice. J Am Coll Cardiol 1985;5:875–81.
Gill JB, Miller D, Boucher CA, Strauss HW. Clinical decision making: dipyridamole thallium imaging. J Nucl Med 1986;27:132–7.
Burns RJ, Galligan L, Wright LM, Lawand S, Burke RJ, Gladstone PJ. Improved specificity of myocardial thallium-201 single-photon emission computed tomography in patients with left bundle branch block. Am J Cardiol 1991;68:504–8.
Author information
Authors and Affiliations
Consortia
Additional information
Supported by a grant from Squibb Diagnostics Canada.
Complete listing in Appendix.
Rights and permissions
About this article
Cite this article
Burns, R.J., Iles, S., Fung, A.Y. et al. The Canadian exercise technetium 99m-labeled teboroxime single-photon emission computed tomographic study. J Nucl Cardiol 2, 117–125 (1995). https://doi.org/10.1016/S1071-3581(95)80022-0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1016/S1071-3581(95)80022-0